June 22, 2026

Chemed Corp (CHE) Stock Analysis: Evaluating Its Potential Upside for Healthcare Investors

Chemed Corp (NYSE: CHE) operates in the healthcare sector, specifically within the medical care facilities industry, and has carved out a unique position through its two primary business segments: VITAS..

Bruker Corporation (BRKR) Stock Analysis: Navigating Promising Terrain in Healthcare with Caution Due to Valuation Concerns

Bruker Corporation (NASDAQ: BRKR), a prominent player in the healthcare sector, specializes in the medical devices industry. With a market capitalization of $8.71 billion, Bruker is a significant entity within..

Regeneron Pharmaceuticals (REGN) Stock Analysis: Unpacking Its 36.62% Potential Upside

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), a prominent player in the biotechnology industry, is capturing the attention of investors with its robust pipeline and promising growth prospects. With a market capitalization..

ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking the 111.79% Potential Upside for Savvy Investors

Investors eyeing the biotechnology sector might find ADMA Biologics Inc (NASDAQ: ADMA) an intriguing prospect. With its current market capitalization sitting at an impressive $1.93 billion, ADMA is a notable..

Madrigal Pharmaceuticals (MDGL) Stock Analysis: A Biotech Gem with a 34% Upside Potential

Investors keeping a keen eye on the biotechnology sector may find Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) an intriguing opportunity. With a current market cap of $11.66 billion, this biopharmaceutical company..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: A Healthcare Heavyweight with a 5.16% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO) is a formidable player in the healthcare sector, with a specialized focus on medical devices. With a market capitalization of $7.56 billion, Bio-Rad has carved..

Ascendis Pharma A/S (ASND) Stock Analysis: Unveiling a 27% Upside Potential with Robust Growth Metrics

Ascendis Pharma A/S (NASDAQ: ASND), a Denmark-based biopharmaceutical innovator, is capturing the attention of investors with its promising upside potential and impressive growth metrics. As a key player in the..

West Pharmaceutical Services, Inc. (WST): Strong Buy Ratings and 9.4% Potential Upside Signal Promising Investment Outlook

West Pharmaceutical Services, Inc. (NYSE: WST) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $23.17 billion,..

Biogen Inc. (BIIB) Investor Outlook: Evaluating the Potential 12% Upside with Strong Buy Ratings

Biogen Inc. (NASDAQ: BIIB) stands as a significant player in the healthcare sector, particularly in the drug manufacturing industry. With a market capitalization of $29.02 billion, Biogen has carved a..

Viatris Inc. (VTRS) Investor Outlook: Is the 15.89% Potential Upside Worth the Risk?

Viatris Inc. (NASDAQ: VTRS), a prominent player in the healthcare sector, is catching the eyes of investors with a 15.89% potential upside, according to recent analyst ratings. This global pharmaceutical..

HealthEquity, Inc. (HQY) Investor Outlook: Analyzing a 35.62% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) stands as a prominent player in the health information services industry, offering a robust platform of technology-enabled services for consumers and employers across the United States...

Charles River Laboratories Inte (CRL): Investor Outlook Reveals 16.4% Potential Upside Amidst Robust Buy Ratings

Charles River Laboratories International, Inc. (NYSE: CRL), a key player in the healthcare sector, specifically within the diagnostics and research industry, presents an intriguing opportunity for investors. With a market..

Amgen Inc. (AMGN) Stock Analysis: Evaluating Its 4.49% Potential Upside for Savvy Investors

Amgen Inc. (NASDAQ: AMGN) stands as a formidable player in the healthcare sector, specifically within the drug manufacturing industry. With a substantial market capitalization of $182.21 billion, Amgen’s footprint in..

Globus Medical, Inc. (GMED) Stock Analysis: Exploring a Potential 37% Upside in the Medical Device Sector

For investors with a keen interest in the healthcare sector, Globus Medical, Inc. (NYSE: GMED) offers a compelling opportunity within the medical device industry. Headquartered in Audubon, Pennsylvania, Globus Medical..

Glaukos Corporation (GKOS) Stock Analysis: Eyeing a 20.52% Upside with Innovative Medical Solutions

Glaukos Corporation (NYSE: GKOS), a leading player in the healthcare sector specializing in medical devices, is capturing the attention of investors with its promising growth potential. With a market capitalization..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Strong Buy Ratings and Innovative Healthcare Solutions Drive Growth Potential

Lantheus Holdings, Inc. (NASDAQ: LNTH), a key player in the healthcare sector, has garnered significant investor interest due to its robust pipeline of diagnostic and therapeutic products. With a market..

GSK plc (GSK) Stock Analysis: Unveiling a Promising 11.77% Potential Upside

With a commanding presence in the healthcare sector, GSK plc (GSK) stands as a formidable player in the Drug Manufacturers – General industry. Headquartered in London, United Kingdom, this pharmaceutical..

DaVita Inc. (DVA) Stock Analysis: Navigating Growth Amidst a Dynamic Healthcare Landscape

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specifically within medical care facilities, offers kidney dialysis services to individuals with chronic kidney failure in the United States...

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Potential Upside of Over 22% Amidst Healthcare Innovation

Inspire Medical Systems, Inc. (NASDAQ: INSP), a notable name in the healthcare sector, is capturing investor attention with its innovative approach to tackling obstructive sleep apnea (OSA) through minimally invasive..

Telix Pharmaceuticals Limited (TLX): Analyst Consensus Points to Over 100% Upside for This Innovative Biotech Stock

Telix Pharmaceuticals Limited (ASX: TLX), a key player in the biotechnology sector focusing on radiopharmaceuticals, stands out with a compelling growth narrative and robust analyst support. Headquartered in North Melbourne,..

Search

Funds

June 22, 2026

Search

Funds

June 22, 2026

FTSE 100

Funds